Peter Johansen

Peter Johansen, PhD, is a seasoned professional in patent examination and biotechnology, currently serving as a Patent Examiner in Art Unit 1644 at the USPTO since August 2020. Expertise includes evaluating patent applications in immunology, neurology, and gene therapy, with a focus on innovative cancer therapies like antibodies and chimeric antigen receptors. Prior to this role, Peter worked as a Patent Agent at Feeney Law Group from November 2016 to July 2020, where responsibilities included drafting patent applications, navigating patent prosecution strategies, and engaging with clients. Earlier experience as a Research Associate at Massachusetts General Hospital involved modeling neurological disorders and collaborating on research, while a role at Harvard Medical School revolved around supporting the establishment of a new Systems Biology department. Peter holds a PhD in Molecular Biology from Boston College, obtained between 2009 and 2015.